INNOVATION
IN
NANOTECHNOLOGY

We develop solutions to unsolved problems of medicine with the use of unique patent-protected nanotechnology.
Our innovations focus on human blood substitutes and targeted cancer therapies.

ABOUT NANOGROUP

NEWS

NanoGroup
Nanogroup - nanotechnology for medicine

eCapital significantly accelerates implementation of investment agreement with NanoGroup

eCapital, the main investor of NanoGroup S.A., on the earlier execution of the investment agreement and a much earlier payment of the remaining funds in the amount of PLN 3.25 million, despite the company not yet having achieved the next investment conditions – this is how Przemysław Mazurek, president of NanoGroup, says about the decision […]

Nanogroup - nanotechnology for medicine

eCaptal makes another investment in NanoGroup

eCapital sp. z o.o., owned by Michał Lach, is investing PLN 4.6 million in the development of NanoGroup. This will be another agreement with this investor, in addition to the one concluded in March this year for the amount of PLN 5.1 million. On September 9, NanoGroup announced that eCapital, owned by Michał Lach, one […]

Nanogroup - nanotechnology for medicine

NanoGroup wants to patent its organ perfusion system

The NanOX project, a unique system for storing and regenerating organs for transplantation, developed by Polish researchers from NanoGroup, is entering its next phase. Following a successful autotransplantation, the company announced that it would file patent applications and is also preparing to certify the NanOX Recovery Box device. NanoGroup S.A. is a dynamically developing research […]

MEDIA RESOURCES

MEDICINE OF TOMORROW

NanoGroup has two development pillars, both targeting critical unsolved medical needs.

ONGOING
PLANNED

RESPIRATORY GASES
EXCHANGE FLUIDS

DISRUPTIVE INNOVATIONS

NANOVELOS PLATFORM:
POLYSACCHARIDE NANOCAPSULES
FOR TARGETED THERAPIES

EASY UPSCALING, LOWER RISK

RESPIRATORY GASES
EXCHANGE FLUIDS

DISRUPTIVE INNOVATIONS
LONG-TERM
One of the biggest unsolved of global medicine
SHORT-TERM
Disrupting change in transplantology

NANOVELOS PLATFORM:
POLYSACCHARIDE NANOCAPSULES
FOR TARGETED THERAPIES

EASY UPSCALING, LOWER RISK
New treatment opportunities with reduced development risk
ONGOING
PLANNED
SEE MORE >

CAREER

Do you set yourself ambitious scientific goals? Do you want to take part in bio-tech and nano-tech medical projects?

NanoGroup is a platform of competence and specialists who share a believe that groundbreaking technologies responding to pressing global challenges can emerge and be developed in Poland.
If you want to join our team, go ahead to contact us!

JOIN OUR TEAM
Copyright © NanoGroup 2024

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.